Infinity Pharmaceuticals Stock Today
PerformanceVery Weak
| Odds Of DistressVery High
|
Infinity Pharmaceuticals has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. The performance scores are derived for the period starting the 26th of January 2025 and ending today, the 25th of February 2025. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 28th of July 2000 | Category Healthcare | Classification Health Care |
Infinity Pharmaceuticals is entity of United States. It is traded as Stock on NASDAQ exchange. The company has 90.76 M outstanding shares of which 2.21 M shares are currently shorted by private and institutional investors with about 0.31 days to cover all short positions. More on Infinity Pharmaceuticals
Moving against Infinity Stock
Infinity Pharmaceuticals cannot be verified against its exchange. It appears that Infinity Pharmaceuticals is not available for investing at the moment. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
RefreshInfinity Stock Highlights
| Senior CEO | Seth JD | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Infinity Pharmaceuticals can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Infinity Pharmaceuticals' financial leverage. It provides some insight into what part of Infinity Pharmaceuticals' total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Infinity Pharmaceuticals (INFIQ) is traded on NASDAQ Exchange in USA and employs 30 people. Infinity Pharmaceuticals is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Nano-Cap' category with a current market capitalization of 908. Infinity Pharmaceuticals classifies itself under Biotechnology sector and is part of Health Care industry. The entity has 90.76 M outstanding shares of which 2.21 M shares are currently shorted by private and institutional investors with about 0.31 days to cover all short positions.
Infinity Pharmaceuticals generates negative cash flow from operations
Check Infinity Pharmaceuticals Probability Of Bankruptcy
Infinity Stock Against Markets
Try Other Suggestions
Additional Tools for Infinity Stock Analysis
When running Infinity Pharmaceuticals' price analysis, check to measure Infinity Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Infinity Pharmaceuticals is operating at the current time. Most of Infinity Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Infinity Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Infinity Pharmaceuticals' price. Additionally, you may evaluate how the addition of Infinity Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.